Urinary C-peptide creatinine ratio detects absolute insulin deficiency in Type 2 diabetes

被引:11
作者
Hope, S. V. [1 ,2 ]
Jones, A. G. [2 ]
Goodchild, E. [2 ]
Shepherd, M. [2 ]
Besser, R. E. J. [2 ]
Shields, B. [2 ]
McDonald, T. [2 ,3 ]
Knight, B. A. [2 ]
Hattersley, A. [2 ]
机构
[1] Royal Devon & Exeter NHS Fdn Trust, Dept Geriatr, Exeter, Devon, England
[2] NIHR Exeter Clin Res Facil, Exeter, Devon, England
[3] Royal Devon & Exeter NHS Fdn Trust, Dept Biochem, Exeter, Devon, England
基金
美国国家卫生研究院; 英国惠康基金;
关键词
BETA-CELL FUNCTION; 10-YEAR FOLLOW-UP; ANTIBODIES; DIAGNOSIS; ADULTS; ONSET; PROGRESSION; MELLITUS; FAILURE;
D O I
10.1111/dme.12222
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AimsTo determine the prevalence and clinical characteristics of absolute insulin deficiency in long-standing Type 2 diabetes, using a strategy based on home urinary C-peptide creatinine ratio measurement. MethodsWe assessed the urinary C-peptide creatinine ratios, from urine samples taken at home 2h after the largest meal of the day, in 191 insulin-treated subjects with Type 2 diabetes (diagnosis age 45years, no insulin in the first year). If the initial urinary C-peptide creatinine ratio was 0.2nmol/mmol (representing absolute insulin deficiency), the assessment was repeated. A standardized mixed-meal tolerance test with 90-min stimulated serum C-peptide measurement was performed in nine subjects with a urinary C-peptide creatinine ratio 0.2nmol/mmol (and in nine controls with a urinary C-peptide creatinine ratio >0.2nmol/mmol) to confirm absolute insulin deficiency. ResultsA total of 2.7% of participants had absolute insulin deficiency confirmed by a mixed-meal tolerance test. They were identified initially using urinary C-peptide creatinine ratio: 11/191 subjects (5.8%) had two consistent urinary C-peptide creatinine ratios 0.2nmol/mmol; 9 of these 11 subjects completed a mixed-meal tolerance test and had a median stimulated serum C-peptide of 0.18nmol/l. Five of these 9 had stimulated serum C-peptide <0.2nmol/l and 9/9 subjects with urinary C-peptide creatinine ratio >0.2 had endogenous insulin secretion confirmed by the mixed-meal tolerance test. Compared with subjects with a urinary C-peptide creatinine ratio >0.2nmol/mmol, those with confirmed absolute insulin deficiency had a shorter time to insulin treatment (median 2.5 vs. 6years, P=0.005) and lower BMI (25.1 vs. 29.1kg/m(2), P=0.04). Two out of the five patients with absolute insulin deficiency were glutamic acid decarboxylase autoantibody-positive. ConclusionsAbsolute insulin deficiency may occur in long-standing Type 2 diabetes, and cannot be reliably predicted by clinical features or autoantibodies. Absolute insulin deficiency in Type 2 diabetes may increase the risk of hypoglycaemia and ketoacidosis, as in Type 1 diabetes. Its recognition should help guide treatment, education and management. The urinary C-peptide creatinine ratio is a practical non-invasive method to aid detection of absolute insulin deficiency, with a urinary C-peptide creatinine ratio > 0.2nmol/mmol being a reliable indicator of retained endogenous insulin secretion.
引用
收藏
页码:1342 / 1348
页数:7
相关论文
共 23 条
  • [1] Urine C-Peptide Creatinine Ratio Is a Noninvasive Alternative to the Mixed-Meal Tolerance Test in Children and Adults With Type 1 Diabetes
    Besser, Rachel E. J.
    Ludvigsson, Johnny
    Jones, Angus G.
    McDonald, Timothy J.
    Shields, Beverley M.
    Knight, Bridget A.
    Hattersley, Andrew T.
    [J]. DIABETES CARE, 2011, 34 (03) : 607 - 609
  • [2] A 12-year prospective study of the relationship between islet antibodies and β-cell function at and after the diagnosis in patients with adult-onset diabetes
    Borg, H
    Gottsäter, A
    Fernlund, P
    Sundkvist, G
    [J]. DIABETES, 2002, 51 (06) : 1754 - 1762
  • [3] Islet cell antibody frequency differs from that of glutamic acid decarboxylase antibodies/IA2 antibodies after diagnosis of diabetes
    Borg, H
    Marcus, C
    Sjöblad, S
    Fernlund, P
    Sundkvist, G
    [J]. ACTA PAEDIATRICA, 2000, 89 (01) : 46 - 51
  • [4] GAD autoantibodies and epitope reactivities persist after diagnosis in latent autoimmune diabetes in adults but do not predict disease progression: UKPDS 77
    Desai, M.
    Cull, C. A.
    Horton, V. A.
    Christie, M. R.
    Bonifacio, E.
    Lampasona, V.
    Bingley, P. J.
    Levy, J. C.
    Mackay, I. R.
    Zimmet, P.
    Holman, R. R.
    Clark, A.
    [J]. DIABETOLOGIA, 2007, 50 (10) : 2052 - 2060
  • [5] DH and Diabetes UK, 2005, STRUCT PAT ED DIAB R
  • [7] The natural course of β-cell function in nondiabetic and diabetic individuals -: The insulin resistance atherosclerosis study
    Festa, A
    Williams, K
    D'Agostino, R
    Wagenknecht, LE
    Haffner, SM
    [J]. DIABETES, 2006, 55 (04) : 1114 - 1120
  • [8] Mixed-Meal Tolerance Test Versus Glucagon Stimulation Test for the Assessment of β-Cell Function in Therapeutic Trials in Type 1 Diabetes
    Greenbaum, Carla J.
    Mandrup-Poulsen, Thomas
    Friedenberg, Paula
    Battelino, Tadej
    Haastert, Burkhard
    Ludvigsson, Johnny
    Pozzilli, Paolo
    Lachin, John M.
    Kolb, Hubert
    [J]. DIABETES CARE, 2008, 31 (10) : 1966 - 1971
  • [9] The clinical utility of C-peptide measurement in the care of patients with diabetes
    Jones, A. G.
    Hattersley, A. T.
    [J]. DIABETIC MEDICINE, 2013, 30 (07) : 803 - 817
  • [10] Urine C-peptide creatinine ratio is an alternative to stimulated serum C-peptide measurement in late-onset, insulin-treated diabetes
    Jones, A. G.
    Besser, R. E. J.
    McDonald, T. J.
    Shields, B. M.
    Hope, S. V.
    Bowman, P.
    Oram, R. A.
    Knight, B. A.
    Hattersley, A. T.
    [J]. DIABETIC MEDICINE, 2011, 28 (09) : 1034 - 1038